— Know what they know.
Not Investment Advice
Also trades as: EWOOF (OTC) · $vol 0M

EBM.V TSXV

Eastwood Bio-Medical Canada Inc.
1W: +7.7% 1M: +4.2% 3M: +101.0% YTD: +105.2% 1Y: +380.5% 3Y: +155.8% 5Y: -0.5%
C$2.00 ($1.40)
+0.05 (+2.56%)
 
Weekly Expected Move ±3.7%
C$2 C$2 C$2 C$2 C$2
TSXV · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 67 · C$137.8M mcap · 21M float · 0.056% daily turnover

Cash Flow Trends

Operating Cash Flow
$19K +226.9% ▲
Capital Expenditures
$3 +0.0% ▲
Free Cash Flow
$19K +226.8% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$18K +189.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$604K-$150K-$547K-$456K-$333K
Depreciation & Amort.$105K$107K$108K$108K$45K
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$394K$34K$418K$312K$304K
Other Non-Cash Items-$12K$5K$4K$21K$3K
Operating Cash Flow-$116K-$4K-$17K-$15K$19K
— Investing Activities —
Capital Expenditures-$6K-$3K-$2$0$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow-$6K-$3K$0$0$0
— Financing Activities —
Net Debt Issuance$20K$26K-$5K-$5K-$211
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow$20K$26K-$5K-$5K-$211
Net Change in Cash-$102K$19K-$21K-$20K$18K
Cash End of Period$21K$40K$18K-$1K$18K
Free Cash Flow-$122K-$7K-$17K-$15K$19K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms